ProFibrix B.V.

FIBROCAPS

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF BLEEDING; TISSUE SEALANTS FOR MEDICAL OR SURGICAL USE; HAEMOSTATIC PHARMACEUTICAL COMPOSITIONS FOR MEDICAL OR SURGICAL USE; POWDER COMPOSITIONS FOR USE AS TISSUE SEALANTS AND/OR HAEMOSTATIC COMPOSITIONS FOR MEDICAL OR SURGICAL USE; COMPOSITIONS FOR TOPICAL APPLICATIONS TO WOUNDS; COMPOSITIONS FOR TOPICAL APPLICATION DURING SURGICAL PROCEDURES;FIBRO CAPS;

FIBROSPRAY

The wording FIBROSPRAY has no meaning in a foreign language.;Surgical, medical, dental and veterinary apparatus and instruments for administration of pharmaceutical compositions, namely, drug delivery systems; Dispensers, sold empty, for the administration of pharmaceutical compositions in powder form by spraying; Dispensers, sold empty, for the administration of haemostatic compositions by spraying; Dispensers, sold empty, for the administration of pharmaceutical powder compositions by spraying for the treatment of bleeding; Dispensers, sold empty, for the topical administration of pharmaceutical powders to surfaces of the body by spraying; Dispensers, sold empty, for the topical administration of haemostatic compositions to the body by spraying; Drug delivery systems for administration of compositions by spraying, for use in operating theatres; Dispensers, sold empty, for the administration of haemostatic compositions to an internal tissue exposed during surgical procedures or after traumatic injury, by spraying;

PROFIBRIX

Pharmaceutical preparations and substances for the treatment of bleeding and for tissue sealing; pharmaceutical preparations and substances for use as tissue sealants; haemostatic pharmaceutical compositions; pharmaceutical powder compositions for use as tissue sealants and/or as haemostatic compositions; pharmaceutical compositions for topical application to wounds; pharmaceutical compositions for topical application during surgical procedures for the treatment of bleeding and for tissue sealing; wound dressings; surgical dressings; bandages for dressing wounds; medicated wound dressings impregnated with tissue sealants and/or haemostatic compositions; medicated bandages impregnated with tissue sealants and/or haemostatic compositions; wound dressings, surgical dressings and bandages for dressing wounds, all incorporating tissue sealants and/or haemostatic compositions; pharmaceutical preparations and substances for use in delivery of drugs, genes, other therapeutic products or diagnostic agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of internal bleeding; blood platelet substitutes; pharmaceutical compositions for coating blood vessels for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical compositions for intravascular administration for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical dry powder compositions comprising fibrin polymer for coating the internal surface of blood vessels for the prevention and treatment of cardiovascular diseases and disorders;The wording PROFIBRIX has no meaning in a foreign language.;Surgical, medical, dental and veterinary apparatus and instruments for administration of pharmaceutical compositions, namely, drug delivery systems; drug delivery systems, sold empty, for the delivery of pharmaceutical compositions for the treatment of bleeding and/or tissue sealing; drug delivery systems, sold empty, for the topical delivery of powdered pharmaceutical tissue sealants and/or haemostatic compositions; drug delivery systems, sold empty, for the delivery of tissue sealants to an internal or external surface of a patient; drug delivery systems, sold empty, for the delivery of haemostatic compositions by spraying; drug delivery systems, sold empty, for the delivery of pharmaceutical tissue sealants and/or haemostatic compositions during surgical procedures; surgical, medical, dental and veterinary apparatus and instruments for the prevention and treatment of cardiovascular diseases and disorders; drug delivery systems, sold empty, for intravascular delivery of pharmaceutical compositions for the prevention and/or treatment of cardiovascular diseases and disorders;Pharmaceutical drug development services; design services of new drug delivery systems; development of pharmaceutical formulations; scientific research and industrial research services in the field of pharmaceuticals and drug delivery systems;

RAPLIXA

Haemostatics for medical purposes; haemostatic pharmaceutical compositions for medical and surgical purposes; tissue sealant substances and compositions for medical and surgical purposes; pharmaceutical compositions and substances for the treatment of bleeding; haemostatic pharmaceutical compositions and tissue sealants for use during surgery; pharmaceutical compositions and substances for use as tissue sealants and haemostatics; dry powder haemostatic and tissue sealant substances and compositions for medical and surgical purposes; haemostatic pharmaceutical compositions for use during surgery; tissue sealant substances and compositions for use during surgery; haemostatic and tissue sealant substances and compositions for application to surgical wounds, traumatic wounds and burns; pharmaceutical substances and compositions for topical application to surgical wounds during surgery; pharmaceutical substances and compositions for the treatment of bleeding during surgery; pharmaceutical substances and compositions for tissue sealing during surgery;Medical devices, namely, dry powder dispensers, sold empty, for delivery of hemostatic substances and compositions; medical devices, namely, dry powder dispensers, sold empty, for delivery of tissue sealant substances and compositions; medical apparatus, namely, dry powder dispensers, sold empty, for delivery of substances and compositions during surgery; medical apparatus, namely, dry powder dispensers, sold empty, for delivery of substances and compositions to surgical wounds, traumatic wounds and burns; medical apparatus, namely, dry powder dispensers, sold empty, for delivery of hemostatic and tissue sealant substances and compositions during surgery; medical apparatus, namely, dry powder dispensers, sold empty, for delivery of dry powder substances and compositions during surgery; medical apparatus, namely, dry powder dispensers for medical use during surgery sold filled with dry powder hemostatic preparations; medical apparatus, namely, dry powder dispensers, sold empty, for topical application of substances and compositions to surgical wounds; medical apparatus, namely, dry powder dispensers, sold empty, for topical application of substances and compositions during surgery; medical apparatus, namely, dry powder dispensers, sold empty, for topical application of substances and compositions to surgical wounds during surgery; medical apparatus, namely, dry powder dispensers, sold empty, for topical application of hemostatic or tissue sealant substances and compositions to surgical wounds during surgery;

RAPLIXAREG

Hemostatics for medical purposes; hemostatic pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; platelet additive solution for medical and clinical use in storing blood components; solutions for medical and clinical use in storing and treating cell tissue; solutions for medical and clinical use in storing and treating blood and blood components; dry powder hemostatic pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in surgery; hemostatic gel matrix preparations for treating wounds; hemostatic gel matrix preparations for treating traumatic wounds and burns; hemostatic gel matrix preparations for treating surgical wound during surgery; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers for medical use sold filled with hemostatic preparations; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers for medical use during surgery sold filled with hemostatic preparations; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers for medical use sold filled with dry hemostatic preparations; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat wounds; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat traumatic wounds and burns; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat surgical wounds;RAPLIXA REG;

RAPLIXASPRAY

Hemostatics for medical purposes; hemostatic pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; platelet additive solution for medical and clinical use in storing blood components; solutions for medical and clinical use in storing and treating cell tissue; solutions for medical and clinical use in storing and treating blood and blood components; dry powder hemostatic pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in surgery; hemostatic gel matrix preparations for treating wounds; hemostatic gel matrix preparations for treating traumatic wounds and burns; hemostatic gel matrix preparations for treating surgical wound during surgery; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers for medical use sold filled with hemostatic preparations; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers for medical use during surgery sold filled with hemostatic preparations; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers for medical use sold filled with dry hemostatic preparations; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat wounds; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat traumatic wounds and burns; Apparatus for delivery of hemostatic substances, namely, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat surgical wounds;RAPLIXA SPRAY;

SYNTHOCYTES

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF THROMBOCYTOPENIA; DRUG DELIVERY AGENTS, NAMELY, MICROCAPSULES FOR INTRODUCTION TO THE BODY OF DRUGS, GENES AND OTHER THERAPEUTIC PRODUCTS OR DIAGNOSTIC AGENTS FOR TREATMENT OF THROMBOCYTOPENIA; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR USE IN DELIVERY OF DRUGS, GENES AND OTHER THERAPEUTIC PRODUCTS OR DIAGNOSTIC AGENTS TO HUMANS FOR TREATMENT OF THROMBOCYTOPENIA; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INTERNAL BLEEDING; PLATELET SUBSTITUTES FOR HUMAN USE;